Adrienne M See

919 citations
9 papers · 414 indexed · h-index 5
Topics
Breast Cancer Treatment Studies (3 papers)Prostate Cancer Diagnosis and Treatment (3 papers)Prostate Cancer Treatment and Research (3 papers)
Partner nations
AustraliaNew Zealand

In The Last Decade

Adrienne M See

9 papers receiving 411 citations

Peers

Adrienne M See
Comparison fields: 5 of 52
  • Oncology 228
  • Pulmonary and Respiratory Medicine 131
  • Cancer Research 122
  • Pathology and Forensic Medicine 84
  • Surgery 84
Replace Alain Tolédano with:
Alain Tolédano France
D. Lam Cham Kee France
Renata Soumarová Czechia
Lara Hathout United States
X. Sanz Spain
Marie-Eve Chand France
Mohamed A. Alm El‐Din Egypt
Elyn H. Wang United States
C.A. Lawton United States
Jeanette Ceberg Sweden
Adrienne M See relative to Alain Tolédano France Alain Tolédano's profile →
Citations per field
00.5×7.7×
Alain Tolédano · 1×
Citations per year

Countries citing papers authored by Adrienne M See

Since Specialization
Citations

This map shows the geographic impact of Adrienne M See's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrienne M See with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrienne M See more than expected).

Fields of papers citing papers by Adrienne M See

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrienne M See. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrienne M See. The network helps show where Adrienne M See may publish in the future.

Co-authorship network of co-authors of Adrienne M See

This figure shows the co-authorship network connecting the top 25 collaborators of Adrienne M See. A scholar is included among the top collaborators of Adrienne M See based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrienne M See. Adrienne M See is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 2
2 3
3 2
4 43
5 230
6 45
7 4
8 18
9 67

About Adrienne M See

Adrienne M See is a scholar working on Radiation, Otorhinolaryngology and Cancer Research, having authored 9 papers that have together received 414 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (3 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Radiation (80 citations), Oncology (228 citations) and Cancer Research (122 citations). Adrienne M See has collaborated with scholars based in Australia and New Zealand. Frequent co-authors include Brigid E Hickey, Mark Jeffery, Phil Hider, Margot Lehman, Daniel Francis, Melissa James, Anne Bernard, Michael Michael, Madeleine King and Marcin Dzienis. Their work appears in journals such as Cochrane Database of Systematic Reviews, Frontiers in Oncology and Practical Radiation Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026